Processing, please wait...
1 lecture / chair

Kristen SLAOUI

Industry Representative
United States
Kristen B. Slaoui, Ph.D. is Chief Corporate Development Officer at Galderma since September 2020. In her role, Dr. Slaoui manages corporate development opportunities to help grow the portfolio across Galderma’s integrated dermatology platform.

Since joining Galderma, she oversaw the acquisition of Alastin Skincare in January 2022, adding to Galderma’s premium portfolio, as well as an agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology, adding this cutting-edge technology to Galderma’s aesthetic injectable portfolio. Her team also secured an exclusive license agreement with Sol-Gel Technologies for the commercialization of EPSOLAY and TWYNEO in the U.S.

Before joining Galderma, Dr. Slaoui spent 20 years with GlaxoSmithKline where she held various roles of increasing seniority. She spent her first six years in the research labs, where her work in pulmonary disease resulted in the discovery of inhaled long-acting muscarinic receptor antagonists found in 3 of their leading products. She holds multiple patents and has authored more than 40 original peer-reviewed publications. After joining GSK’s Business and Corporate Development teams in 2006, she executed more than $30 billion worth of deals and acquisitions, including the $3.6 billion acquisition of Stiefel Laboratories in 2009, adding a dermatology division to GSK’s global portfolio, where she then became VP of Business Development.

Dr. Slaoui earned bachelor’s degrees in both Biology and Classical Studies from Gettysburg College. She earned a Ph.D. in Physiology from The Johns Hopkins Bloomberg School of Public Health and completed an NIH Post-Doctoral Fellowship in Pharmacology at the University of Washington in Seattle, WA. While in Respiratory Drug Discovery at GSK, she continued her commitment to academic research, spending more than a decade as an adjunct assistant professor at her alma mater, The Johns Hopkins Bloomberg School of Public Health
read more
add item add Kristen SLAOUI

Kristen SLAOUI's schedule

IMCAS World Congress 2023